TNF and colitis: In a TNBS rat colitis model, Escherichia coli Nissle 1917, at low doses of the strain (107cfu/day), has been demonstrated to reduce the disease activity index, colonic MPO activity, and TNF‐α levels and to increase IL‐10 expression (Sha et al., 2014).